iShares Biotechnology ETF
522 hedge funds and large institutions have $4.15B invested in iShares Biotechnology ETF in 2016 Q4 according to their latest regulatory filings, with 127 funds opening new positions, 172 increasing their positions, 148 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
10% less capital invested
Capital invested by funds: $4.63B → $4.15B (-$479M)
16% less funds holding in top 10
Funds holding in top 10: 25 → 21 (-4)
35% less call options, than puts
Call options by funds: $641M | Put options by funds: $990M
Holders
522
Holding in Top 10
21
Calls
$641M
Puts
$990M
Top Buyers
| 1 | +$45.3M | |
| 2 | +$45.1M | |
| 3 | +$43.9M | |
| 4 |
N
Natixis
Paris,
France
|
+$39.9M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$33.8M |
Top Sellers
| 1 | -$247M | |
| 2 | -$160M | |
| 3 | -$157M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$77.1M |
| 5 |
SG Americas Securities
New York
|
-$54.5M |